Guangzhou Wondfo Biotech Co.,Ltd Stock
Equities
300482
CNE100002102
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
24.36 CNY | -0.81% | -1.58% | -19.26% |
Oct. 24 | Guangzhou Wondfo Biotech Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2024 | CI |
Sep. 27 | Guangzhou Wondfo Biotech Co.,Ltd announced a financing transaction | CI |
Capitalization | 11.64B 1.6B 1.51B 1.41B 1.25B 2.26B 136B 2.48B 17.47B 6.45B 55.8B 6.02B 5.89B 242B | P/E ratio 2024 * |
18.1x | P/E ratio 2025 * | 14.2x |
---|---|---|---|---|---|
Enterprise value | 11.64B 1.6B 1.51B 1.41B 1.25B 2.26B 136B 2.48B 17.47B 6.45B 55.8B 6.02B 5.89B 242B | EV / Sales 2024 * |
3.56x | EV / Sales 2025 * | 2.95x |
Free-Float |
54.9% | Yield 2024 * |
-
| Yield 2025 * | - |
1 day | -0.81% | ||
1 week | -1.58% | ||
Current month | -0.25% | ||
1 month | -7.34% | ||
3 months | +19.29% | ||
6 months | -11.42% | ||
Current year | -19.26% |
Director | Title | Age | Since |
---|---|---|---|
Zhong Xiong Peng
CEO | Chief Executive Officer | 50 | 2023-01-18 |
Fang Xia Yu
DFI | Director of Finance/CFO | 48 | 2012-04-10 |
Jun Hua
IRC | Investor Relations Contact | - | - |
Manager | Title | Age | Since |
---|---|---|---|
Wen Mei Li
BRD | Director/Board Member | 62 | 1991-12-31 |
Ji Hua Wang
CHM | Chairman | 62 | 2016-07-20 |
Xiao Wei He
BRD | Director/Board Member | 65 | 2012-04-10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.21% | 12 M€ | -16.71% | - |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
-0.81% | -1.58% | -23.76% | -33.97% | 1.6B | ||
+0.51% | +1.75% | +0.63% | -20.98% | 12.26B | ||
-0.42% | -0.22% | -9.17% | +49.50% | 7.44B | ||
+4.00% | +3.35% | +25.60% | +238.01% | 6.44B | ||
+1.11% | +0.67% | +16.84% | -41.75% | 5.85B | ||
-1.36% | +2.39% | +41.30% | -61.42% | 4.49B | ||
-1.12% | -2.53% | -21.00% | -18.61% | 3.55B | ||
-0.58% | -2.45% | +14.48% | +119.23% | 2.7B | ||
-0.05% | -2.61% | +13.74% | -57.69% | 2.69B | ||
+1.76% | -1.94% | -66.93% | -88.75% | 1.96B | ||
Average | +0.30% | -0.39% | -0.83% | +8.36% | 4.9B | |
Weighted average by Cap. | +0.53% | +0.22% | +4.51% | +20.34% |
2024 * | 2025 * | |
---|---|---|
Net sales | 3.27B 450M 425M 394M 352M 635M 38.15B 696M 4.9B 1.81B 15.65B 1.69B 1.65B 67.9B | 3.95B 544M 514M 477M 425M 768M 46.16B 842M 5.93B 2.19B 18.94B 2.04B 2B 82.15B |
Net income | 649M 89.29M 84.39M 78.29M 69.82M 126M 7.58B 138M 973M 359M 3.11B 335M 328M 13.49B | 818M 113M 106M 98.78M 88.08M 159M 9.56B 174M 1.23B 453M 3.92B 423M 414M 17.01B |
Net Debt | - | - |
Date | Price | Change | Volume |
---|---|---|---|
24-12-09 | 24.36 ¥ | -0.81% | 5,832,257 |
24-12-06 | 24.56 ¥ | +1.32% | 6,913,398 |
24-12-05 | 24.24 ¥ | +0.54% | 3,844,545 |
24-12-04 | 24.11 ¥ | -1.95% | 5,571,969 |
24-12-03 | 24.59 ¥ | -0.65% | 5,885,930 |
End-of-day quote Shenzhen S.E., December 08, 2024
More quotesQuarterly revenue - Rate of surprise
- Stock Market
- Equities
- 300482 Stock